Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q2 2024 | 1 | $0.07 | $0.07 | $0.07 |
Q3 2024 | 1 | $0.02 | $0.02 | $0.02 |
Q4 2024 | 2 | $0.08 | $0.08 | $0.08 |
Q1 2025 | 2 | $0.07 | $0.07 | $0.07 |
Q2 2025 | 1 | $0.21 | $0.21 | $0.21 |
Q3 2025 | 1 | $0.15 | $0.16 | $0.15 |
Q4 2025 | 1 | $0.19 | $0.19 | $0.19 |
Bioventus Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.06 by $0. The company had revenue of 138.96 M for the quarter and had revenue of 512.35 M for the year. Bioventus Inc. has generated $-2 earnings per share over the last year ($-2.49 diluted earnings per share) and currently has a price-to-earnings ratio of -17.64. Bioventus Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/05/2024 | Q3 2024 | $0.06 | -$0.07 | -0.13 | $133.24 M | $138.96 M |
08/06/2024 | Q2 2024 | $0.07 | -$0.37 | -0.44 | $151.22 M | |
05/07/2024 | Q1 2024 | -$0.05 | -$0.07 | -0.02 | $129.46 M | |
03/12/2024 | Q4 2023 | $0.06 | -$0.10 | -0.16 | $135.42 M | |
11/07/2023 | Q3 2023 | $0.06 | -$0.12 | -0.18 | $120.79 M | |
08/08/2023 | Q2 2023 | $0.03 | -$0.06 | -0.09 | $137.07 M | |
05/16/2023 | Q1 2023 | -$0.11 | -$1.61 | -1.5 | $119.06 M | |
03/31/2023 | Q4 2022 | -$0.72 | $125.83 M | |||
11/21/2022 | Q3 2022 | $0.13 | -$1.18 | -1.31 | $128.66 M | |
08/12/2022 | Q2 2022 | -$0.13 | $140.33 M | |||
05/11/2022 | Q1 2022 | -$0.24 | $117.29 M | |||
03/11/2022 | Q4 2021 | -$0.01 | $130.41 M | |||
11/10/2021 | Q3 2021 | -$0.03 | $108.89 M | |||
08/11/2021 | Q2 2021 | -$0.10 | $109.82 M | |||
05/13/2021 | Q1 2021 | $0.60 | $81.78 M | |||
03/26/2021 | Q4 2020 | $0.07 | $98.59 M | |||
09/30/2020 | Q3 2020 | $0.15 | $85.91 M | |||
06/30/2020 | Q2 2020 | -$0.10 | $58.02 M | |||
03/31/2020 | Q1 2020 | $0.20 | $78.65 M | |||
12/31/2019 | Q4 2019 | $0.10 | $97.55 M |
Bioventus Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based off last year's report dates.
The conference call for Bioventus Inc.'s latest earnings report can be listened to online.
The conference call transcript for Bioventus Inc.'s latest earnings report can be read online.
Bioventus Inc. (:BVS) has a recorded annual revenue of $512.35 M.
Bioventus Inc. (:BVS) has a recorded net income of $512.35 M. Bioventus Inc. has generated $-2.49 earnings per share over the last four quarters.
Bioventus Inc. (:BVS) has a price-to-earnings ratio of -17.64 and price/earnings-to-growth ratio is -2.33.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED